« Previous
Next »
Experimental Hematology
Volume 35, Issue 3
, Pages 407-415
, March 2007
Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy
References
- . Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2000;2:41–52
- Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer. 2002;38:2128–2136
- . Evolution of beetle bioluminescence: the origin of beetle luciferin. Luminescence. 2004;19:8–20
- Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques. 2003;35:1022–1030
- Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging. 2004;3:117–124
- Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. Cancer Lett. 2005;217:243–253
- Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2000;2:491–495
- Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery. 2006;58:365–372
- The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther. 2002;9:844–849
- . Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res. 2004;122:225–230
- Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging. 2004;3:1–8
- Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis. 2003;20:733–744
- Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer. Prostate. 2004;59:292–303
- . In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. Br J Cancer. 2004;90:1259–1264
- . Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood. 2003;101:640–648
- . Overriding imatinib resistance with a novel ABL kinase inhibitor. Science. 2004;305:399–401
- Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. Proc Natl Acad Sci U S A. 2005;102:10640–10645
- Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell. 2005;7:129–141
- Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci U S A. 2004;101:16909–16914
- . In vivo imaging of NF-kappa B activity. J Immunol. 2002;168:1441–1446
- . Light emission requires exposure to the atmosphere in ex vivo bioluminescence imaging. Mol Imaging. 2006;5:53–56
- . Development of a 1.0 T MR microscope using a Nd-Fe-B permanent magnet. Magn Reson Imaging. 2001;19:875–880
- Imaging of living mice using a 1-T compact magnetic resonance imaging system. J Magn Reson Imaging. 2006;24:901–907
- . MRI measurement of liver regeneration in mice following partial hepatectomy. Magn Reson Med. 2004;52:177–180
- Magnetic resonance imaging provides accurate and precise volume determination of the regenerating mouse liver. J Gastrointest Surg. 2004;8:806–811
- . Course of murine leukemia retrovirus infection determined in vivo by magnetic resonance imaging. Lab Invest. 1990;63:568–575
- In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals. Eur J Nucl Med Mol Imaging. 2006;33:557–565
- . The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151–1168
- . The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999;189:1399–1412
- . Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004;14:559–578
- . In vivo imaging of light-emitting probes. J Biomed Opt. 2001;6:432–440
- . Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab Invest. 2002;82:1563–1571
- Imaging transgene expression in live animals. Mol Ther. 2001;4:239–249
- Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. Biotechniques. 2003;34:1184–1188
- Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J Magn Reson Imaging. 1993;3:41–49
- . Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol. 2004;14:5–13
- . MRI detection of early bone metastases in b16 mouse melanoma models. Clin Exp Metastasis. 2005;22:403–411
PII: S0301-472X(06)00702-8
doi: 10.1016/j.exphem.2006.11.006
© 2007 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 35, Issue 3
, Pages 407-415
, March 2007
